Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease
| Published in: | Genes and Diseases |
|---|---|
| Main Authors: | Eva Gijbels, Kevin De Muynck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Aude Vanlander, Frederik Berrevoet, Bart Hendrikx, Anne Hoorens, Hans Van Vlierberghe, Mathieu Vinken, Lindsey Devisscher |
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2023-01-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S235230422200040X |
Similar Items
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
by: Kevin De Muynck, et al.
Published: (2021-10-01)
by: Kevin De Muynck, et al.
Published: (2021-10-01)
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
by: Bart Vanderborght, et al.
Published: (2020-10-01)
by: Bart Vanderborght, et al.
Published: (2020-10-01)
Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition
by: Vânia Vilas-Boas, et al.
Published: (2020-03-01)
by: Vânia Vilas-Boas, et al.
Published: (2020-03-01)
The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis
by: Hanife Yurdakul Ertan, et al.
Published: (2023-01-01)
by: Hanife Yurdakul Ertan, et al.
Published: (2023-01-01)
Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD
by: Anneleen Heldens, et al.
Published: (2025-06-01)
by: Anneleen Heldens, et al.
Published: (2025-06-01)
Quality of life after open versus laparoscopic preperitoneal mesh repair for unilateral inguinal hernias
by: Simon Corthals, et al.
Published: (2021-10-01)
by: Simon Corthals, et al.
Published: (2021-10-01)
Gamma-Glutamyl Transferase: A Friend against Cholestatic Itch? A Retrospective Observational Data Analysis in Patients with Extrahepatic Cholestasis
by: Floris W. Haijer, et al.
Published: (2023-01-01)
by: Floris W. Haijer, et al.
Published: (2023-01-01)
Neonatal Cholestasis Progressing to a Multisystem Syndrome With Liver Cirrhosis in Two Siblings With FARSA Deficiency: An Evolving Hepatological Phenotype
by: Y. Aelvoet, et al.
Published: (2025-05-01)
by: Y. Aelvoet, et al.
Published: (2025-05-01)
Proteomics data in vitiligo: a scoping review
by: Danique Berrevoet, et al.
Published: (2024-04-01)
by: Danique Berrevoet, et al.
Published: (2024-04-01)
Canonical and Non-Canonical Roles of Connexin43 in Cardioprotection
by: Olga M. Rusiecka, et al.
Published: (2020-08-01)
by: Olga M. Rusiecka, et al.
Published: (2020-08-01)
Effects of propofol and sevoflurane on hepatic blood flow: a randomized controlled trial
by: Jurgen van Limmen, et al.
Published: (2020-09-01)
by: Jurgen van Limmen, et al.
Published: (2020-09-01)
Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience
by: Bart Hendrikx, et al.
Published: (2025-10-01)
by: Bart Hendrikx, et al.
Published: (2025-10-01)
HES1 and HES4 have non-redundant roles downstream of Notch during early human T-cell development
by: Matthias De Decker, et al.
Published: (2020-01-01)
by: Matthias De Decker, et al.
Published: (2020-01-01)
Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?
by: Luís Filipe Abreu de Carvalho, et al.
Published: (2023-09-01)
by: Luís Filipe Abreu de Carvalho, et al.
Published: (2023-09-01)
Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma
by: H. Degroote, et al.
Published: (2018-01-01)
by: H. Degroote, et al.
Published: (2018-01-01)
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice
by: Roni F. Kunst, et al.
Published: (2024-01-01)
by: Roni F. Kunst, et al.
Published: (2024-01-01)
Cephalexin Induced Cholestatic Jaundice
by: Abhinav Agrawal, et al.
Published: (2014-01-01)
by: Abhinav Agrawal, et al.
Published: (2014-01-01)
Current Therapies for Cholestatic Diseases
by: Nahum Méndez-Sánchez, et al.
Published: (2023-06-01)
by: Nahum Méndez-Sánchez, et al.
Published: (2023-06-01)
Editorial: Open Preperitoneal Mesh Repair for Inguinal Hernia – New Evidence, Old Arguments
by: Frederik Berrevoet
Published: (2025-08-01)
by: Frederik Berrevoet
Published: (2025-08-01)
The Transition from Experimental Data to Clinical Practice Using P4HB Mesh in Ventral Hernia Repair
by: Frederik Berrevoet
Published: (2022-02-01)
by: Frederik Berrevoet
Published: (2022-02-01)
Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody
by: Roos Van Den Noortgate, et al.
Published: (2023-01-01)
by: Roos Van Den Noortgate, et al.
Published: (2023-01-01)
The Role of Inflammation in Cholestatic Liver Injury
by: Chen J, et al.
Published: (2023-10-01)
by: Chen J, et al.
Published: (2023-10-01)
Cholestatic hepatitis due to Salmonella typhi
by: Ayse Albayrak, et al.
Published: (2011-04-01)
by: Ayse Albayrak, et al.
Published: (2011-04-01)
Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in CholestasisSummary
by: Ludovica Ceci, et al.
Published: (2024-01-01)
by: Ludovica Ceci, et al.
Published: (2024-01-01)
OBSTETRIC CHOLESTASIS
by: Pramila Pradhan
Published: (2003-01-01)
by: Pramila Pradhan
Published: (2003-01-01)
Challenges in the diagnosis of biliary atresia in cholestatic neonates
by: Ming-Wei Lai
Published: (2023-01-01)
by: Ming-Wei Lai
Published: (2023-01-01)
Naringin in cholestatic liver ischemia-reperfusion injury
by: Arif Aslaner, et al.
Published: (2025-06-01)
by: Arif Aslaner, et al.
Published: (2025-06-01)
Gut microbiota dysbiosis in infantile cholestatic hepatopathy
by: Yi Zou, et al.
Published: (2025-03-01)
by: Yi Zou, et al.
Published: (2025-03-01)
Fatal Cholestatic Hepatitis in an Infant: An Unusual Etiology
by: Mark R Oliver, et al.
Published: (1995-01-01)
by: Mark R Oliver, et al.
Published: (1995-01-01)
Medical Management of Chronic Cholestatic Liver Diseases
by: Andrea A Gossard, et al.
Published: (2000-01-01)
by: Andrea A Gossard, et al.
Published: (2000-01-01)
Giant Cell Arteritis Presenting as Cholestatic Hepatitis
by: Gerald Riordan, et al.
Published: (2021-01-01)
by: Gerald Riordan, et al.
Published: (2021-01-01)
Cholestatic Pruritus in Children: Conventional Therapies and Beyond
by: Minna Rodrigo, et al.
Published: (2023-05-01)
by: Minna Rodrigo, et al.
Published: (2023-05-01)
Prolonged Cholestatic Liver Disease Secondary to Methotrexate
by: Yahya Atayan, et al.
Published: (2015-12-01)
by: Yahya Atayan, et al.
Published: (2015-12-01)
Human Hepatocellular response in Cholestatic Liver Diseases
by: Kimberly Ortiz, et al.
Published: (2023-12-01)
by: Kimberly Ortiz, et al.
Published: (2023-12-01)
Fibrotic Events in the Progression of Cholestatic Liver Disease
by: Hanghang Wu, et al.
Published: (2021-05-01)
by: Hanghang Wu, et al.
Published: (2021-05-01)
Involvement of Autophagy in Ageing and Chronic Cholestatic Diseases
by: Claudio Pinto, et al.
Published: (2021-10-01)
by: Claudio Pinto, et al.
Published: (2021-10-01)
Systematic review: efficacy of therapies for cholestatic pruritus
by: Ebehiwele Ebhohon, et al.
Published: (2023-05-01)
by: Ebehiwele Ebhohon, et al.
Published: (2023-05-01)
Reversine attenuates cholestatic ductular reaction in rats
by: Di Huang, et al.
Published: (2023-05-01)
by: Di Huang, et al.
Published: (2023-05-01)
Nutritional evaluation of children with chronic cholestatic disease
by: Francislaine Veiga da Silva, et al.
Published: (2016-03-01)
by: Francislaine Veiga da Silva, et al.
Published: (2016-03-01)
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency
by: Sigrid Wahlen, et al.
Published: (2022-07-01)
by: Sigrid Wahlen, et al.
Published: (2022-07-01)
Similar Items
-
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
by: Kevin De Muynck, et al.
Published: (2021-10-01) -
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
by: Bart Vanderborght, et al.
Published: (2020-10-01) -
Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition
by: Vânia Vilas-Boas, et al.
Published: (2020-03-01) -
The Investigation of Therapeutic Implications of Mast Cell Stabilizer Cromolyn Sodium on Cholestasis and Cholestatic Pruritus in Experimental Cholestasis
by: Hanife Yurdakul Ertan, et al.
Published: (2023-01-01) -
Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD
by: Anneleen Heldens, et al.
Published: (2025-06-01)
